DWTX
Dogwood Therapeutics, Inc.
Key Financials
Net Income
$-34257370
↓ 177.4%
Operating Income
$-27968445
↓ 128.7%
Total Liabilities
$15.3M
↓ 49.1%
EPS (Diluted)
$-7.13
↑ 43.1%
Total Assets
$90.2M
↓ 4.4%
Shareholders' Equity
$74.9M
↑ 839.8%
Cash & Equivalents
$6.5M
↓ 56.1%
Operating Cash Flow
$-15618651.00
↓ 77.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DWTX |
| Company Name | Dogwood Therapeutics, Inc. |
| CIK | 1818844 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8666208655 |